Latest Nureca stock price

Nureca P/E Ratio

NURECA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
72.08
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 72.08
Current Price ₹282.80
EPS (TTM) ₹0.85
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 12.68
Historical Range 12.68 - 12.68
Percentile 100.0%

Sector Context

Sector Average 53.26
Sector Median 30.38
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹6.43
Sept 2025 ₹3.63
Mar 2025 ₹2.47

Key P/E Ratio Insights for Nureca

  • Stock appears overvalued with PE of 72.08, suggesting caution for new investments
  • Current PE is 468.5% above historical average
  • Trading at premium to sector average PE of 53.26

View the NURECA equity price for detailed stock performance.

P/E Ratio Historical Trend for Nureca

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2021 12.68 50.92 ₹645.75 NSE Low

Sector P/E Ratio Comparison

Comparing Nureca with other companies in Healthcare sector
Sector Average
53.26
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low